11.7 C
London
Thursday, September 21, 2023

Emerging Growth Conference 62 September 6 & 7. Register now

From lying about the state of containment of the coronavirus or the state of labor camps where a million or more ethnic minorities toil to lying about intellectual property theft, China lies and lies big. And so do its companies. But not like they used to. The frauds of the early 2000s were both the biggest and the most colorful.
Key points: First dosing of AD-214 achieved in Phase I extension study On track to obtain interim results in 2023, full results in Q1 2024 Will generate valuable data to inform and de-risk the Phase II study design ...
Unlocking Chronic Diseases with Next-Gen i-body Platform Technology from AdAlta (1AD) 1AD stock carries a dramatically undervalued profile against its blue-sky upside target Emerging Growth Report on AdAlta (ASX:1AD) Over time, medicine has evolved in waves to treat unmet medical needs.  Think...
Epazz, Inc. (OTC Pink: EPAZ) a mission-critical provider of drone technology, blockchain cryptocurrency mobile apps and cloud-based business software solutions, announced today that CryObo Technology would help farmers tokenize their crops through the issuance of NFT tokens in order...
MELBOURNE Australia, 13 July 2023: AdAlta Limited (ASX:1AD), the clinical stage drug discovery company developing novel therapeutic products from its i-body platform is pleased to report it has completed placement of the Shortfall facility under the non-renounceable pro rata...
Key points: • New data favourably links AD-214 preclinical animal studies and Phase I human clinical trial results to provide important dose frequency insights • AD-214 is designed to treat fibrotic diseases such as Idiopathic Pulmonary Fibrosis (IPF) by inhibiting the effect of the chemokine...
29 June 2023 ASX Announcement IMPORTANT PHASE I EXTENSION CLINICAL STUDY OF AD-214 APPROVED Key highlights: Human Research Ethics Committee (HREC) has approved Phase I extension clinical study of AD-214 Clinical study is important to extend prior Phase I findings, support...
The cryptosphere, teeming with opportunity and complexity, is redefining the boundaries of traditional investing. Cryptocurrencies, which were once the obscure fascination of technophiles, have burgeoned into a vibrant financial frontier, commanding global attention and offering a plethora of investment...
America may run on Dunkin, but before you know it, Americans may soon be running for a sip of perfectly crafted cold brew coffee with hints of kiwi, orange, and pineapple. That is because Reborn Coffee is bursting onto...
With Memorial, Independence, and Labor Day approaching, it is Patriotic season. Time to fly those flags, have those barbecues, and sport that red, white, and blue. But is it also time to invest like a Patriot? Meet American Rebel,...
We have all heard the phrase “healthier for you” being thrown around these days. We all strive for it, but let’s face it, sometimes it is just easier (or cheaper) to grab the fast-food option in a busy lifestyle....

MOST POPULAR